Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01716975 |
|
Recruitment Status :
Completed
First Posted : October 30, 2012
Last Update Posted : May 3, 2016
|
Sponsor:
FORUM Pharmaceuticals Inc
Collaborators:
Syneos Health
NeuroCog Trials, Inc.
Information provided by (Responsible Party):
FORUM Pharmaceuticals Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Actual Primary Completion Date : | February 2016 |
| Actual Study Completion Date : | February 2016 |